Effect of opium addiction on new and traditional cardiovascular risk factors: Do duration of addiction and route of administration matter?

Lipids in Health and Disease

Volumn 7, Issue , 2008, Pages

  Asgary, Sedigheh ^a   Sarrafzadegan, Nizal ^b   Naderi, Gholam Ali ^b   Rozbehani, Reza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MORPHINE; TRIACYLGLYCEROL; OPIATE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROL GROUP; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE;

ADULT; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MORPHINE; OPIOID-RELATED DISORDERS; OPIUM; RISK FACTORS;

EID: 57049090543     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-7-42     Document Type: Article

References (24)

1. Metabolic engineering with a morphine biosynthetic P450 in opium poppy surpasses breeding. S Frick R Kramell TM Kutchana, Metab Engineering 2007 9 169 176 10.1016/j.ymben.2006.10.004
2. A Tale of Three Cell Types: Alkaloid biosynthesis Is localized to sieve elements in opium poppy. DA Bird VR Franceschi PJ Facchini, Plant Cell 2003 15 2626 2635 14508000 10.1105/tpc.015396
3. Effects of opium addiction on some serum factors in addicts with non-insulindependent diabetes mellitus. G Karam M Reisi AA Kaseb M Khaksari A Mohammadi M Mahmoodi, Addic Biol 2004 9 53 58 10.1080/13556210410001674095
4. Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in Adult. National Cholesterol Education Program(NCEP), JAMA 1993 269 3015 23 10.1001/jama.269.23.3015 8501844
5. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clin Chem 1972 18 6 499 502 4337382
6. Detection of variability in apo(a) gene transcription regulatory sequences using the DGGE method. K Zídková V Kebrdlová L Zlatohlávek R Češka, Clinica Chimica Acta 2007 376 77 81 10.1016/j.cca.2006.07.016
7. Lipid pentad index: a novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India. B Das MK Daga SK Gupta, Clinical Biochemistry 2006 40 18 23 10.1016/j.clinbiochem.2006.08.016 17052698
8. The connection between X-reactive protein and atherosclerosis. Sk Singh Mv Suresh B Voleti A Agrawal, Ann Med 2008 40 2 110 20 10.1080/07853890701749225 18293141
9. Association of plasma fibrinogen and factor clotting activity with coronary heart disease and stroke. AR Rudnicka S Mt-Isa TW Meade, J thromb Haemost 2006 4 11 2405 10 10.1111/j.1538-7836.2006.02221.x 17002654
10. ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. C Schmidt B Fagerberg, Atherosclerosis 2008 196 2 817 22 10.1016/j.atherosclerosis.2007.01.017 17337270
11. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms. L Jiaa H Baia M Fua Y Xub Y Yanga S Long, Clinica Chimica Acta 2006 360 37 45 10.1016/j.cccn.2005.04.004
12. The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. TM Forte MR McCall, Curr Opin Lipidol 1994 5 354 64 10.1097/00041433-199410000-00007 7858910
13. High density lipoprotein and lipoprotein oxidation. CL Banka, Curr Opin Lipidol 1996 7 139 42 8818510
14. Regulation of leucocyte endothelial interactions of special relevance to atherogenesis. MA Vadas JR Gamble K Rye P Barter, Clin Exp Pharmacol Physiol 1997 24 A33 5 10.1111/j.1440-1681.1997.tb03052.x 9143795
15. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. M Koga M Otsuki S Matsumoto H Saito M Mukai S Kasayama, Clinica Chimica Acta 2007 378 48 52 10.1016/j.cca.2006.10.013
16. Effect of opium addiction on diabetes. L Azod M Rashidi M Afkhami-Ardekani G Kiani F Khoshkam, Am J Drug Alcohol Abuse 2008 34 4 383 8 10.1080/00952990802122580 18584567
17. Attenuation of morphine tolerance and dependence by aminoguanidine in mice. AO Abdel-Zaher MM Hamdy SA Aly RH Abdel-Hady S Abdel-Rahman, Eur J Pharmacol 2006 540 60 66 10.1016/j.ejphar.2006.03.059 16730698
18. Twelvemonth maintenance treatment of opium-dependent patients. J Ahmadi M Babaee-Beigi M Alishahi I Maany T Hidari, J Subst Abuse Treat 2004 26 61 64 10.1016/S0740-5472(03)00141-7
19. Why does the rapid delivery of drugs to the brain promote addiction? A Samaha T Robinson, Trends in Pharmacological Sciences 2005 26 82 87 10.1016/j.tips.2004.12.007 15681025
20. Medicinal smokes. A Mohagheghzadeh P Faridi F Shams-Ardakani Y Ghasemi, J Ethnopharmacol 2006 108 2 161 184 10.1016/j.jep.2006.09.005 17030480
21. Enhanced prolactin level in opium smokers. GR Moshtaghi-Kashanian F Esmaeeli S Dabiri, Addic Biol 2005 10 4 345 34 10.1080/13556210500351263
22. Association between smoking, hematological parameters, and metabolic syndrome in Japanese Men. N Ishizaka Y Ishizaka E Toda R Nagai M Yamakado, Diabetes Care 2006 29 741 10.2337/diacare.29.03.06.dc05-2245 16505543
23. The metabolic syndrome in smokers: the D.E.S.I.R. study. C Geslain-Biquez S Vol J Tichet A Caradec A D'Hour B Balkau, Diabetes Metab 2003 29 226 234 10.1016/S1262-3636(07)70031-9 12909810
24. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. TP Whitehead D Robinson SL Allaway AC Hale, Clin Lab Haematol 1995 17 131 138 8536415